Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation, and translocation of cytochrome b-245

J H Wandall, J H Wandall

Abstract

The effects of omeprazole on polymorphonuclear neutrophil (PMN) chemotaxis, superoxide generation, degranulation and translocation of cytochrome b-245 were investigated. Omeprazole (10(-6) - 5 x 10(-3) mol/l) reduced chemotaxis under agarose in a dose dependent manner, and the effect was irreversible. Superoxide anion generation was inhibited 50% at a concentration of 2.5 x 10(-5) mol/l and completely abolished at 5 x 10(-3) mol/l. Acid degraded omeprazole also inhibited O2- generation. Omeprazole did not scavenge O2- generated in a cell free xanthin-xanthine oxidase system. Degranulation by PMNs was inhibited only by omeprazole in concentrations above 10(-4) mol/l. Translocation of cytochrome b-245, essential for generation of O2-, was not affected by omeprazole. In conclusion, the anti-ulcer agent omeprazole in concentrations obtained during intravenous administration may inhibit the function of PMNs in vitro.

References

    1. Biochem Med. 1977 Aug;18(1):52-7
    1. Biochem Biophys Res Commun. 1979 Sep 12;90(1):214-9
    1. J Biol Chem. 1985 Oct 25;260(24):13237-47
    1. J Biol Chem. 1985 Oct 25;260(24):13248-55
    1. J Med Chem. 1986 Aug;29(8):1327-9
    1. Biochem Biophys Res Commun. 1985 Jul 31;130(2):621-6
    1. N Engl J Med. 1985 Apr 11;312(15):958-61
    1. Biochem Med. 1970 Aug;4(1):61-8
    1. Biochim Biophys Acta. 1984 Dec 19;778(3):549-58
    1. FEBS Lett. 1982 Nov 22;149(1):113-6
    1. J Biol Chem. 1983 Apr 10;258(7):4059-62
    1. J Cell Biol. 1983 Jul;97(1):52-61
    1. Nature. 1981 Apr 2;290(5805):406-9
    1. J Cell Biol. 1980 Jul;86(1):21-8
    1. J Biol Chem. 1976 Dec 10;251(23):7690-8
    1. Anal Biochem. 1976 May 7;72:248-54
    1. Hum Pathol. 1985 Oct;16(10):973-8
    1. Calcif Tissue Int. 1986 Feb;38(2):123-5
    1. Digestion. 1986;34(2):78-86
    1. J Immunol. 1985 Nov;135(5):3439-47
    1. J Cell Biol. 1968 May;37(2):394-411
    1. J Biol Chem. 1984 Jun 10;259(11):7143-50
    1. Nature. 1981 Mar 12;290(5802):159-61
    1. Biochem J. 1982 May 15;204(2):479-85
    1. Biochim Biophys Acta. 1962 Apr 23;58:593-5
    1. Biochim Biophys Acta. 1978 Jul 7;525(1):37-44
    1. J Immunol. 1975 Dec;115(6):1650-6

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel